Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/1996
03/21/1996WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008484A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/21/1996WO1996008261A1 Probiotic compositions
03/21/1996WO1996008243A1 Pharmaceutical preparation containing metformin and a process for producing it
03/21/1996DE4432757A1 Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung Pharmaceutical composition comprising metformin and methods of their production
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199944A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702026A2 Modified bile acids, a process for their production and their use
03/20/1996EP0702015A1 Bicyclic oxazole and thiazole substituted ethers
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent
03/20/1996EP0701991A1 Process for the preparation of lignin analogues and starting materials therefor
03/20/1996EP0701839A2 Therapeutic products containing organic ashes emitting 'far' infrared radiation
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701439A1 Stable copper(i) complexes and methods related thereto
03/20/1996EP0505465B1 4-Heterocyclyl-piperidine derivatives, their preparation and their use as inhibitors of calcium overload in brain cells
03/20/1996EP0482108B1 Substituted 2-imidazolines and preparation and use thereof
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996CN1118782A Cyclohexan-derivative, preparation and application for treatment of same
03/20/1996CN1118781A Heterocyclic compound with activity against diabetes and preparation and application of same
03/20/1996CN1118766A A hexagonal molecular structure water manufacturing apparatus and a method thereof
03/19/1996US5500436 2-(N-(2-aminomethyl)amino)acetic acid derivatives to inhibit advanced glycosylation
03/19/1996US5500434 Mixture of trandolapril and felodipine
03/19/1996US5500429 Cardiovascular
03/19/1996US5500426 Administered to improve glucose tolerance
03/19/1996US5500415 Process for the preparation of spherules of active principles and emulsions containing the spherules
03/19/1996US5500212 Bile acid sequesterant, anticholesterol
03/19/1996CA1338168C Antibiotic ll-e19020 alpha and beta
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996WO1996007397A2 Delivery of solid drug compositions
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996CA2157950A1 Bicyclic oxazole and thiazole substituted ethers
03/13/1996EP0700905A1 Tricyclic pyrazole derivatives
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700683A1 Insulin analog formulations
03/13/1996EP0700681A1 Nutritional transfusion for peripheral vein administration
03/13/1996EP0700401A1 Human calcium sensor
03/13/1996EP0700397A1 New thiazolidindiones and drugs containing them
03/13/1996EP0644760A4 Treatments for diseases characterized by neovascularization.
03/13/1996EP0476113B1 Medicament for treating hyperlipidaemia and/or atherosclerosis
03/13/1996CN1118595A Anthranilic acid derivative
03/13/1996CA2157998A1 Pharmaceutical compounds
03/13/1996CA2157851A1 Insulin analog formulations
03/12/1996US5498728 Osteoporosis
03/12/1996US5498626 Acylaminoindole derivatives as 5-ht1 agonists
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/12/1996US5498617 Bone disorders
03/12/1996US5498607 Anticholesterol agents
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives
03/07/1996WO1996006605A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/06/1996EP0699672A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/06/1996EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties
03/06/1996EP0699437A1 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins
03/06/1996EP0699187A1 DERIVATIVES OF -g(b), -g(b)-DIMETHYL-4-PIPERIDINEETHANAMINE AS INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS
03/06/1996EP0699072A1 Iron-binding polymers for oral administration
03/06/1996CN1118163A Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
03/06/1996CN1117970A Derivative of 5,6-dihydro-4H-thieno|3,4-c¨ pyrrole, preparation and medical application of same
03/06/1996CN1117965A Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines
03/06/1996CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1117868A Chinese medicinal preparation for curing infantile maldevelopment and preparation method thereof
03/05/1996US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
03/05/1996US5496803 Administering prolactin by itself or with a glucosteroid such as cortisol
03/05/1996US5496801 Storage stability, mannitol, citric acid buffer
03/05/1996US5496545 Phosphate-binding polymers for oral administration
03/05/1996CA2056058C Corandomized fat compositions for infant formulas
03/01/1996CA2157236A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
02/1996
02/29/1996WO1996006101A1 Amino acid chelates having improved palatability
02/29/1996WO1996005842A1 Intravenous alendronate formulations
02/29/1996WO1996005838A2 Combined preparation for the therapy of immune diseases
02/29/1996WO1996005837A1 Use of n-substituted phenothiazines
02/29/1996WO1996005820A1 Hyperlipemia remedy
02/29/1996WO1996005816A1 Treatment of animals
02/29/1996WO1996005740A1 Nervonic acid compositions
02/29/1996DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects
02/29/1996DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines
02/29/1996CA2198452A1 Treatment of animals
02/29/1996CA2198368A1 Hyperlipemia remedy
02/29/1996CA2198256A1 Use of n-substituted phenothiazines
02/28/1996EP0698609A1 Alpha-phosphorus substituted sulfinate derivatives as squalene synthetase inhibitors
02/28/1996EP0698392A1 Compositions containing a RAR alpha specific ligand and at least one fatty acid
02/28/1996EP0698113A1 Production of toxin binding biopolymers, use thereof
02/28/1996EP0698012A1 Novel deoxygalactonojirimycin derivatives
02/28/1996EP0698010A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
02/28/1996EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996EP0697821A1 Cholesterol lowering drink mix compositions
02/28/1996CN1117735A Steroids for treating menopausal complaints
02/28/1996CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants
02/27/1996US5495048 Anticholesterol agents
02/27/1996US5494934 Antidepressants, hypotensive agents
02/27/1996US5494933 Treatment
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1298